Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration.
Duplancic. Bozidar B; Stambolija. Vasilije V; Holjevac. Jadranka J; Zemba. Mladen M; Balenovic. Igor I; Drmic. Domagoj D; Suran. Jelena J; Radic. Bozo B; Filipovic. Marinko M; Blagaic. Alenka Boban AB; Brcic. Luka L; Kolenc. Danijela D; Grabarevic. Zeljko Z; Seiwerth. Sven S; Sikiric. Predrag P
Key Findings
- BPC‑157 prevented anaphylactoid reactions when given before a dextran or egg‑white IV challenge.
- BPC‑157 rescued animals even when administered after the reaction had started.
- Standard antihistamine (chloropyramine) and H2‑blocker (cimetidine) were only moderately effective, and adding them to BPC‑157 did not improve the outcome.
Practical Outcomes
- For biohackers, this study suggests BPC‑157 might have strong anti‑allergic properties at ultra‑low doses, but the evidence is limited to rodents and IV exposure. Until human data are available, it’s not ready for a reliable protocol, though it adds a promising clue for future research on using BPC‑157 to mitigate severe allergic reactions.
Summary
In rats and mice, a single tiny dose of the peptide BPC‑157 (as low as 10 pg per kilogram) stopped severe allergic‑like reactions caused by injecting dextran or egg white, and it could also rescue animals that were already reacting. Standard allergy drugs worked only a little, while BPC‑157 alone was much more effective.
Abstract
Anesthetized mice or rats received intravenously 6%, 10%, 20%, 40%, 60%, 80%, and 90% dextran and/or white egg (1ml/rat or 0.15ml/mouse) into their tails. Medication (/kg b.w., 5ml/kg) was given intraperitoneally (BPC 157 10µg, 1µg, 10ng, and 10pg/kg, chloropyramine 20mg/kg, and cimetidine 10mg/kg intraperitoneally, alone or in combination while controls received an equivolume of saline), immediately after challenge or, alternatively, at 5min after or 24 or 48h before challenge. The effect was assessed at 5, 10, 20 and 30min after dextran and/or white egg challenge. We commonly noted prominent edema involving the face, upper and lower lip, snout, paws and scrotum (presented with extreme cyanosis), poor respiration and the number of fatalities after dextran and/or white egg application. Contrary, BPC 157 regimens (10µg, 1µg, 10ng, and 10pg/kg) effectively, may both prevent anaphylactoid reactions that may arise from dextran and/or white egg application and furthermore, rescue already advanced reactions when given after the challenge. Chloropyramine and cimetidine given alone were only moderately effective. When given together with BPC 157, the observed effect correlates with the strong effect of BPC 157 given alone.
Study Information
pubmed
2014
2014-01-31T00:00:00.000Z
10.1016/j.ejphar.2014.01.046